Open | $43.250 |
Close | $43.080 |
Volume / Avg. | 494.870K / 326.253K |
Day Range | 42.960 - 44.270 |
52 Wk Range | 1.960 - 53.820 |
Market Cap | $1.398B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | % |
Days to Cover | 8.37 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Soleno Therapeutics (NASDAQ: SLNO) through any online brokerage.
Other companies in Soleno Therapeutics’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT) and Prothena Corp (NASDAQ:PRTA).
The latest price target for Soleno Therapeutics (NASDAQ: SLNO) was reported by Piper Sandler on Monday, February 5, 2024. The analyst firm set a price target for 93.00 expecting SLNO to rise to within 12 months (a possible 115.88% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Soleno Therapeutics (NASDAQ: SLNO) is $43.08 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Soleno Therapeutics.
Soleno Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Soleno Therapeutics.
Soleno Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.